Abbott | ABT - Выручка от реализации

Биржевая цена
91.37
Изменение за день
-2.49 -2.65%
Ежемесячно
-10.32%
Ежегодный
-30.12%
Q2 прогноз
89.18




Продажи Изменить Дата
Abbott USD 11.16B 300M 2026-03
Agilent USD 1.8B 63M 2025-12
AtriCure USD 140.5M 6.2M 2025-12
Baxter International USD 2.97B 130M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Bio-Rad Laboratories USD 693.2M 40.2M 2025-12
Boston Scientific USD 5.2B 90M 2026-03
Cooper Companies USD 1.02B 41.1M 2025-12
Danaher USD 5.95B 890M 2026-03
Dexcom USD 1.26B 50M 2025-12
Edwards Lifesciences USD 1.65B 80M 2026-03
Globus Medical USD 826.4M 57.4M 2025-12
Insulet USD 783.8M 77.5M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
Intuitive Surgical USD 2.77B 100M 2026-03
J&J USD 24.1B 500M 2026-03
Masimo USD 412.5M 41M 2025-12
Medtronic USD 9B 39M 2026-01
Merit Medical Systems USD 393.9M 9.7M 2025-12
Pfizer USD 17.58B 880M 2025-12
Smith & Nephew USD 3.18B 353M 2025-12
Solventum Corp USD 1.99B 110M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Tandem Diabetes Care USD 290.4M 41.15M 2025-12
Teleflex USD 568.98M 344.02M 2025-12
Terumo JPY 296.63B 21.66B 2025-12
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Zimmer Biomet Holdings USD 2.09B 150M 2026-03